author-photo

A. M. Fink

Iowa State University

123

Papers

4258

Citations

Citation Trend

Filter By

Papers (95) Sort By

Journal Conference Others

Obinutuzumab in Allogeneic Transplantation for CLL and Richter’s Transformation in the Age of Targeted Therapies

2021
Show All
- Source
- Cite
- Save
Citations (0)
VENETOCLAX-OBINUTUZUMAB MODULATES CLONAL GROWTH: RESULTS OF A POPULATION-BASED MINIMAL RESIDUAL DISEASE MODEL FROM THE RANDOMIZED CLL14 STUDY

2021 Hematological Oncology
Show All
- Source
- Cite
- Save
Citations (0)
GENETIC MARKERS AND OUTCOME WITH FRONT LINE OBINUTUZUMAB PLUS EITHER CHLORAMBUCIL OR VENETOCLAX - UPDATED ANALYSIS OF THE CLL14 TRIAL

2021 Hematological Oncology
Show All
- Source
- Cite
- Save
Citations (0)
VENETOCLAX‐OBINUTUZUMAB FOR PREVIOUSLY UNTREATED CHRONIC LYMPHOCYTIC LEUKEMIA: 4‐YEAR FOLLOW‐UP ANALYSIS OF THE RANDOMIZED CLL14 STUDY

2021 Hematological Oncology
Show All
- Source
- Cite
- Save
Citations (1)
HIGH EFFICACY OF VENETOCLAX PLUS OBINUTUZUMAB IN PATIENTS WITH COMPLEX KARYOTYPE (CKT) AND CHRONIC LYMPHOCYTIC LEUKEMIA (CLL): A PROSPECTIVE ANALYSIS FROM THE CLL14 TRIAL: S106

2019
Show All
- Source
- Cite
- Save
Citations (0)
FIXED-DURATION VENETOCLAX PLUS OBINUTUZUMAB IMPROVES PROGRESSION-FREE SURVIVAL AND MINIMAL RESIDUAL DISEASE NEGATIVITY IN PATIENTS WITH PREVIOUSLY UNTREATED CLL AND COMORBIDITIES: S149

2019
Show All
- Source
- Cite
- Save
Citations (0)
Mode of progression correlates with further clinical outcome of chronic lymphocytic leukemia (CLL). A meta-analysis by the German CLL study group

2017
Show All
- Source
- Cite
- Save
Citations (0)
CLL2-BIG - a sequential treatment regimen of Bendamustine followed by GA101 and Ibrutinib followed by Ibrutinib and GA101 maintenance in patients with Chronic Lymphocytic Leukemia (CLL): Interim results of a phase II-trial by the German CLL Study Group

2016
Show All
- Source
- Cite
- Save
Citations (0)
More severe infectious complications in CLL patients treated with fludarabine, cyclophosphamide, rituximab (FCR) in comparison to bendamustin plus rituximab (BR): Results of the interim-analysis of the CLL10 trial of the German CLL Study Group

2014
Show All
- Source
- Cite
- Save
Citations (0)
98.30 The isoperimetric inequality for quadrilaterals

2014 The Mathematical Gazette
- A. M. Fink
Show All
- Source
- Cite
- Save
Citations (0)